Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · PRECIGEN, INC. (PGEN)

Precigen stockholders approve 7 million share increase to 2023 incentive plan

Neutral Impact 2 of 5 shareholder Written later

At its June 18, 2026 annual meeting, Precigen stockholders approved an amendment adding 7 million shares to the 2023 Omnibus Incentive Plan for equity awards. The same meeting re-elected all nine directors, ratified Deloitte & Touche LLP as auditor for fiscal 2026, and approved the non-binding executive pay resolution, so the plan change is the only item that affects the share pool.

Key points

  • Plan amendment approved: 207,056,264 for, 4,996,260 against, 234,326 abstain, with 61,452,809 broker non-votes
  • All nine directors were elected to one-year terms, including Randal Kirk and Nancy Howell Agee
  • Deloitte & Touche LLP ratified as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 272,813,907 votes for

The filing

CompanyPRECIGEN, INC. (PGEN)
Form8-K, current report
Filed with the SECJun 24, 2026, 4:07 PM ET
Accession number0000950103-26-009441

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 24, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.